• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Executive Vice Chairman Schoenberg Roy was granted 25,000 shares, increasing direct ownership by 23% to 133,302 units (SEC Form 4)

    8/14/25 4:33:43 PM ET
    $AMWL
    Real Estate
    Real Estate
    Get the next $AMWL alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Schoenberg Roy

    (Last) (First) (Middle)
    C/O AMERICAN WELL CORPORATION
    75 STATE STREET, 26TH FLOOR

    (Street)
    BOSTON MA 02109

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    American Well Corp [ AMWL ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    X Officer (give title below) Other (specify below)
    Executive Vice Chairman
    3. Date of Earliest Transaction (Month/Day/Year)
    08/13/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Class A Common Stock 08/13/2025 A(1) 25,000 A $0.00 133,302(2) D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. Represents a grant of restricted stock units, which vest over a three-year period from the grant date, with equal installments vesting on each of the first, second and third anniversaries of the grant date.
    2. On July 10, 2024, the issuer effected a 1-for-20 reverse split of the issuer's common stock, resulting in proportionate adjustments to the number of shares of Class A common stock beneficially owned by the reporting person, including shares underlying outstanding restricted stock units ("RSUs"). Accordingly, the securities reported on this Form 4 have been adjusted to reflect the 1-for-20 reverse stock split.
    /s/ Anna Nesterova as attorney-in-fact for Roy Schoenberg 08/14/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $AMWL alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AMWL

    DatePrice TargetRatingAnalyst
    1/13/2025$15.00Equal Weight → Overweight
    Wells Fargo
    8/3/2023$5.00 → $2.50Overweight → Equal-Weight
    Morgan Stanley
    3/23/2023$5.00 → $2.50Outperform → Market Perform
    TD Cowen
    2/27/2023$5.00 → $3.50Overweight → Neutral
    Piper Sandler
    1/4/2023$4.20Neutral → Buy
    BofA Securities
    9/7/2022$5.00Hold
    Truist
    4/14/2022$6.00Buy
    Guggenheim
    4/1/2022$5.00Neutral
    Credit Suisse
    More analyst ratings

    $AMWL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Amwell makes grant to new employees under inducement plan

    BOSTON, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL), a leading technology-enabled care platform provider, announces that on August 8, Amwell made grants of RSUs covering an aggregate of 76,198 shares of its Class A common stock to two new employees. The grants were offered as material inducement to the employees' employment with Amwell. The RSUs will vest as follows, subject to the applicable employee's continued employment through the applicable vesting date: 25% of the RSUs will vest upon the first anniversary of the grant date ("Initial Vesting Date"), and the remaining 75% of the RSUs will vest in equal pro rata increments every three months thereafter (beginning on the first

    8/8/25 4:05:00 PM ET
    $AMWL
    Real Estate

    Amwell® Announces Results for Second Quarter 2025

    BOSTON, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the second quarter ended June 30. The company's second quarter earnings report may be viewed at investors.amwell.com. Amwell will host a conference call to discuss its financial results today at 5 p.m. ET. The call can be accessed via a live audio webcast at https://edge.media-server.com/mmc/p/ve8zytc3/. A webcast replay will be available for approximately 90 days at investors.amwell.com. About Amwell Amwell offers payers and health systems a single, comprehensive, technology-enabled care platform. W

    8/5/25 4:05:00 PM ET
    $AMWL
    Real Estate

    Amwell set to continue to enable U.S. Defense Health Agency healthcare teams to deliver connected and seamless in-person and virtual care for the Military Health System ("MHS")

    BOSTON, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL), a leading technology-enabled care platform provider, announced that as part of a Leidos-led partnership, it has been awarded an extension of its next-generation Digital First contract to power the digital transformation of the Military Health System (MHS), which serves approximately 9.6 million beneficiaries. Under the contract extension, Amwell will continue to provide its comprehensive technology-enabled care platform to power virtual care delivered by MHS providers. The platform for scheduled virtual visits has been successfully deployed, on time and on budget, across the global DOD enterprise and to the U.S. Military Entra

    8/5/25 8:30:31 AM ET
    $AMWL
    Real Estate

    $AMWL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Executive Vice Chairman Schoenberg Roy was granted 25,000 shares, increasing direct ownership by 23% to 133,302 units (SEC Form 4)

    4 - American Well Corp (0001393584) (Issuer)

    8/14/25 4:33:43 PM ET
    $AMWL
    Real Estate

    Chairman, co-CEO Schoenberg Ido was granted 50,000 shares, increasing direct ownership by 78% to 114,250 units (SEC Form 4)

    4 - American Well Corp (0001393584) (Issuer)

    8/14/25 4:33:31 PM ET
    $AMWL
    Real Estate

    President, International Gotlib Phyllis sold $42,773 worth of shares (4,958 units at $8.63), decreasing direct ownership by 3% to 136,891 units (SEC Form 4)

    4 - American Well Corp (0001393584) (Issuer)

    7/1/25 4:35:20 PM ET
    $AMWL
    Real Estate

    $AMWL
    SEC Filings

    View All

    SEC Form 10-Q filed by American Well Corporation

    10-Q - American Well Corp (0001393584) (Filer)

    8/5/25 4:10:20 PM ET
    $AMWL
    Real Estate

    American Well Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - American Well Corp (0001393584) (Filer)

    8/5/25 4:08:01 PM ET
    $AMWL
    Real Estate

    American Well Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - American Well Corp (0001393584) (Filer)

    6/17/25 4:57:19 PM ET
    $AMWL
    Real Estate

    $AMWL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Amwell upgraded by Wells Fargo with a new price target

    Wells Fargo upgraded Amwell from Equal Weight to Overweight and set a new price target of $15.00

    1/13/25 7:29:38 AM ET
    $AMWL
    Real Estate

    Amwell downgraded by Morgan Stanley with a new price target

    Morgan Stanley downgraded Amwell from Overweight to Equal-Weight and set a new price target of $2.50 from $5.00 previously

    8/3/23 6:19:10 AM ET
    $AMWL
    Real Estate

    Amwell downgraded by TD Cowen with a new price target

    TD Cowen downgraded Amwell from Outperform to Market Perform and set a new price target of $2.50 from $5.00 previously

    3/23/23 7:15:52 AM ET
    $AMWL
    Real Estate

    $AMWL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by American Well Corporation

    SC 13G/A - American Well Corp (0001393584) (Subject)

    11/12/24 4:43:25 PM ET
    $AMWL
    Real Estate

    SEC Form SC 13G filed by American Well Corporation

    SC 13G - American Well Corp (0001393584) (Subject)

    11/6/24 4:14:27 PM ET
    $AMWL
    Real Estate

    SEC Form SC 13G filed by American Well Corporation

    SC 13G - American Well Corp (0001393584) (Subject)

    11/4/24 11:53:44 AM ET
    $AMWL
    Real Estate

    $AMWL
    Financials

    Live finance-specific insights

    View All

    Amwell® Announces Results for Second Quarter 2025

    BOSTON, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the second quarter ended June 30. The company's second quarter earnings report may be viewed at investors.amwell.com. Amwell will host a conference call to discuss its financial results today at 5 p.m. ET. The call can be accessed via a live audio webcast at https://edge.media-server.com/mmc/p/ve8zytc3/. A webcast replay will be available for approximately 90 days at investors.amwell.com. About Amwell Amwell offers payers and health systems a single, comprehensive, technology-enabled care platform. W

    8/5/25 4:05:00 PM ET
    $AMWL
    Real Estate

    Amwell® to report second quarter 2025 operating results; company leaders to attend upcoming investor conferences

    BOSTON, July 22, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, will report second quarter 2025 operating results after stock market trading hours on Tuesday, Aug. 5. Following the distribution of the earnings alert via wire services, the Amwell management team will host a live conference call and webcast at 5 p.m. ET to review the company's operating results and provide a general business update. The full earnings report and the live audio webcast can be accessed by visiting the Investors section of the company's website. A webcast replay of the call will be available at investors.amwell

    7/22/25 4:05:00 PM ET
    $AMWL
    Real Estate

    Amwell® Announces Results for First Quarter 2025

    BOSTON, May 01, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL) a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the first quarter ended March 31. Visit Amwell's investor relations website at investors.amwell.com to view the first quarter 2025 earnings report. The company will host a conference call to discuss its financial results today at 5 p.m. ET, May 1. The call can be accessed via a live audio webcast at https://edge.media-server.com/mmc/p/9tn5fcf6. A replay of the call will be available via webcast shortly after the completion of the call, at investors.amwell.com. About Amwell Amwell offers payers and

    5/1/25 4:05:00 PM ET
    $AMWL
    Real Estate

    $AMWL
    Leadership Updates

    Live Leadership Updates

    View All

    Amwell announces new chief financial officer

    BOSTON, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL), a leader in digital care, today announced Mark Hirschhorn will become Amwell Chief Financial Officer (CFO) effective Oct. 21, succeeding Robert "Bob" Shepardson, who has been in the role since 2021. Hirschhorn will oversee Amwell's financial operations, enterprisewide optimization and capital allocation activities, and will play a meaningful leadership role in guiding the company's strategy to support its long-term growth objectives and enhance shareholder value.   Hirschhorn is a healthcare technology industry leader, with over three decades of experience in financial and strategic operations, having served in senior executiv

    10/15/24 4:30:00 PM ET
    $AMWL
    Real Estate

    Amwell Announces Appointment of Ricky Goldwasser to its Board of Directors

    Boston, June 17, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL), a leader in hybrid care enablement, today announces the appointment of Ricky Goldwasser to the company's Board of Directors, effective June 13. "Ricky brings to our board a deep financial background that makes her an invaluable addition as we focus on Amwell's path to profitability. Ricky's strong voice coupled with her impressive track record will help guide Amwell as we strive for greater efficiencies, optimized cash flow and profitable growth, while remaining committed to enabling our clients to achieve their goals. We are pleased to welcome Ricky to the team," said Ido Schoenberg, M.D., CEO and chairman, Amwell. Ms. Gol

    6/17/24 8:05:00 AM ET
    $AMWL
    Real Estate

    Axogen, Inc. Appoints Kathy Weiler to its Board of Directors

    ALACHUA, Fla. and TAMPA, Fla., Dec. 26, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, is pleased to announce today the appointment of Mrs. Kathy Weiler to its Board of Directors, effective December 20, 2023. Weiler, a senior executive with 20+ years of experience and proven track record in driving strategic commercial initiatives, will serve on the Board's Governance, Nominating and Sustainability Committee, and the Quality, Compliance, and Portfolio Management Committee. "I am happy to welcome Kathy to the Board as Axogen is approaching an exciting inflection point in its journ

    12/26/23 4:15:00 PM ET
    $AMWL
    $AXGN
    Real Estate
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care